|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.35 EUR | +0.17% |
|
+8.50% | -6.54% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 74.36 | +25.49% | 9 | ||||||
| 1,276.96 | +6.63% | 26 | ||||||
| 270.59 | +1.74% | 22 | ||||||
| 267.79 | +4.23% | 28 | ||||||
| 363.92 | +1.06% | 18 | ||||||
| 153.99 | -1.95% | 21 | ||||||
| 211.84 | +23.53% | 22 | ||||||
| 317.2 | -2.85% | 24 | ||||||
| 356.69 | -5.2% | 29 | ||||||
| 157.52 | +20.69% | 27 | ||||||
| 28.75 | +16.53% | 26 | ||||||
| 62.96 | +0.64% | 24 | ||||||
| 554.91 | +15.85% | 23 | ||||||
| 96.14 | +23.59% | 23 | ||||||
| 21.39 | +9.08% | 20 | ||||||
| 9,686.67 | +41.45% | 15 | ||||||
| 6,262.69 | +8.56% | 16 | ||||||
| 80.33 | +49.88% | 15 | ||||||
| 54.92 | +16.27% | 18 | ||||||
| 4.142 | +11.89% | 17 | ||||||
| Average | 1,015.19 | +13.36% | 21 | ||||||
| Weighted average by Cap. | 699.32 | +7.27% | 24 |
- Stock Market
- Stocks
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
